Artisan Partners Limited Partnership Immuno Gen, Inc. Transaction History

Artisan Partners Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$12.46 - $29.95 $31.8 Million - $76.4 Million	-2,552,260 Reduced 68.52%	1,172,323 $34.8 Million
Q3 2023 Nov 09, 2023	SELL	$14.09 - $19.87 $18,852 - $26,586	-1,338 Reduced 0.04%	3,724,583 $59.1 Million
Q2 2023 Aug 10, 2023	BUY	$3.75 - $20.05 $2.04 Million - $10.9 Million	544,542 Added 17.12%	3,725,921 $70.3 Million
Q1 2023 May 11, 2023	BUY	$3.67 - $4.92 $11.7 Million - $15.7 Million	3,181,379 New	3,181,379 $12.2 Million

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Artisan Partners Limited Partnership with notifications on news.